phosphatidylcholines has been researched along with aluminum sulfate in 2 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (aluminum sulfate) | Trials (aluminum sulfate) | Recent Studies (post-2010) (aluminum sulfate) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 1,585 | 78 | 714 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asai, T; Ichikawa, K; Miyauchi, H; Oku, N; Shimizu, K; Urakami, T; Yonezawa, S | 1 |
| Hook, S; McBurney, WT; Myschik, J; Rades, T | 1 |
2 other study(ies) available for phosphatidylcholines and aluminum sulfate
| Article | Year |
|---|---|
Enhanced desensitization efficacy by liposomal conjugation of a specific antigen.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antigens; Cholesterol; Desensitization, Immunologic; Dose-Response Relationship, Immunologic; Drug Administration Schedule; Enzyme-Linked Immunosorbent Assay; Female; Hypersensitivity; Immunoglobulin E; Immunoglobulin G; Liposomes; Mice; Mice, Inbred BALB C; Ovalbumin; Phosphatidylcholines; Spleen; Tissue Distribution | 2007 |
Immunostimulatory lipid implants containing Quil-A and DC-cholesterol.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies; Antibody Formation; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cholesterol; Drug Compounding; Drug Implants; Immunity, Cellular; Injections; Kinetics; Liposomes; Lymphocyte Activation; Male; Mice; Mice, Inbred C57BL; Ovalbumin; Phosphatidylcholines; Quillaja Saponins; Saponins; Solubility; Vaccines | 2008 |